Education
About Us
Working with TipRanks
Follow Us
DIVP - ETF AI Analysis
Top Page
Cullen Enhanced Equity Income ETF (DIVP)
Rating:73Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.
Generally Positive Recent Performance
The ETF has shown steady gains over the past month, three months, and year to date, indicating recent upward momentum.
Multiple Strong Health Care Holdings
Several top positions in the health care sector have delivered solid gains, supporting the fund’s overall results.
Negative Factors
Moderately High Expense Ratio
The fund’s fee is on the higher side for an ETF, which can slowly reduce net returns over time compared with lower-cost options.
Heavy U.S. Concentration
With most assets in U.S. companies and very limited exposure abroad, the fund is heavily tied to the performance of the U.S. market.
Some Weak Top Holdings
A few of the largest positions, particularly in technology and financials, have shown weak performance year to date, which can drag on overall returns.
DIVP vs. SPDR S&P 500 ETF (SPY)
AUM45.68M
RegionNorth America
Expense Ratio0.55%
Beta0.48
IssuerCullen
Inception DateMar 06, 2024
Dividend Yield5.7%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume6,480
30 Day Avg. Volume8,463
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.20Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering34
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DIVP Summary
The Cullen Enhanced Equity Income ETF (DIVP) is an actively managed fund that invests across the total U.S. stock market with a goal of providing both growth and steady income. It holds a mix of sectors like health care, financials, energy, and technology, with well-known companies such as Merck and IBM among its top positions. Investors might consider DIVP if they want broad diversification plus an income focus, which can appeal to long-term, income-minded investors. A key risk is that the fund’s stock holdings can go up and down with the overall market, so your investment value may fluctuate.
How much will it cost me?The Cullen Enhanced Equity Income ETF (DIVP) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This expense ratio is higher than average for ETFs because it is actively managed, requiring more resources to implement its enhanced equity income strategy. Active management often involves more research and trading compared to passively managed funds, which track an index.
What would affect this ETF?The Cullen Enhanced Equity Income ETF (DIVP) could benefit from stable or improving economic conditions in the U.S., as its focus on income-producing assets and diverse sector exposure, including health care, financials, and consumer defensive, supports resilience and growth. However, rising interest rates or regulatory changes affecting key sectors like energy and financials may negatively impact its performance. Additionally, shifts in market sentiment toward income-focused strategies could influence investor demand for this ETF.
DIVP Top 10 Holdings
DIVP is leaning heavily on steady, dividend-friendly U.S. names, with health care and energy doing much of the heavy lifting. Merck and Bristol-Myers are rising and help anchor the fund’s health care tilt, while ConocoPhillips and EOG Resources ride firm energy markets to push returns higher. Verizon has also woken up, adding some welcome spark from communications. On the softer side, Medtronic has been more mixed, occasionally losing steam and muting some of that strength. Overall, the ETF is diversified but clearly powered by defensive health care and energy plays.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Merck & Company | 4.53% | $2.05M | $297.38B | 29.07% | 80 Outperform | |
| Conocophillips | 4.22% | $1.91M | $144.87B | 30.12% | 78 Outperform | |
| Medtronic | 3.93% | $1.78M | $124.16B | 1.64% | 80 Outperform | |
| Cisco Systems | 3.79% | $1.71M | $311.88B | 26.44% | 77 Outperform | |
| Bristol-Myers Squibb | 3.72% | $1.68M | $124.67B | 4.20% | 78 Outperform | |
| EOG Resources | 3.60% | $1.63M | $68.68B | 4.90% | 78 Outperform | |
| PPL | 3.41% | $1.54M | $28.74B | 11.72% | 66 Neutral | |
| Sysco | 3.37% | $1.53M | $41.97B | 17.72% | 71 Outperform | |
| VICI Properties | 3.36% | $1.52M | $32.28B | -7.75% | 73 Outperform | |
| Exxon Mobil | 3.30% | $1.49M | $632.64B | 42.09% | 74 Outperform |
DIVP Technical Analysis
Neutral
―
Price Trends
26.20
Positive
25.32
Positive
24.88
Positive
Market Momentum
0.28
Positive
57.48
Neutral
41.56
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVP, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 27.10, equal to the 50-day MA of 26.20, and equal to the 200-day MA of 24.88, indicating a neutral trend. The MACD of 0.28 indicates Positive momentum. The RSI at 57.48 is Neutral, neither overbought nor oversold. The STOCH value of 41.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DIVP.
DIVP Peer Comparison
Comparison Results
Performance Comparison
DIVP
Cullen Enhanced Equity Income ETF
27.04
2.68
11.00%
BAMD
Brookstone Dividend Stock ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
RFDA
RiverFront Dynamic US Dividend Advantage ETF
―
―
―
VAMO
Cambria Value & Momentum ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents